Cargando…
Effects of Suramin on Polycystic Kidney Disease in a Mouse Model of Polycystin-1 Deficiency
The aberrant activation of the purinergic signaling pathway has been shown to promote cyst growth and fluid secretion in autosomal dominant polycystic kidney disease (ADPKD). Suramin is an anti-parasitic drug that has strong anti-purinergic properties. Whether suramin could have a therapeutic effect...
Autores principales: | Chang, Ming-Yang, Hsu, Shen-Hsing, Ma, Li-Yi, Chou, Li-Feng, Hung, Cheng-Chieh, Tian, Ya-Chung, Yang, Chih-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369130/ https://www.ncbi.nlm.nih.gov/pubmed/35955634 http://dx.doi.org/10.3390/ijms23158499 |
Ejemplares similares
-
Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency
por: Chang, Ming-Yang, et al.
Publicado: (2017) -
Regulation of STATs by polycystin-1 and their role in polycystic kidney disease
por: Weimbs, Thomas, et al.
Publicado: (2013) -
Effect of Trehalose Supplementation on Autophagy and Cystogenesis in a Mouse Model of Polycystic Kidney Disease
por: Chou, Li-Fang, et al.
Publicado: (2018) -
Leptospirosis kidney disease: Evolution from acute to chronic kidney disease
por: Chou, Li-Fang, et al.
Publicado: (2023) -
Polycystin-1 Expression in Fetal, Adult and Autosomal Dominant Polycystic Kidney
por: Chae, Seoung Wan, et al.
Publicado: (2006)